Publications
Research & patents
Peer-reviewed research, patents and book chapters from our team — spanning CAR-T engineering, drug discovery and pharmacology. Team members are highlighted in author lists.
Research record · 1988–2025
| Type | Entries | Share |
|---|---|---|
| Research papers | 44 | 48% |
| Granted patents | 3 | 3.3% |
| Patents filed | 43 | 47% |
| Book chapters | 2 | 2.2% |
| Decade | Entries |
|---|---|
| 1980s | 6 |
| 1990s | 5 |
| 2000s | 61 |
| 2010s | 13 |
| 2020s | 6 |
Showing 92 of 92 entries
2020s6 entries
- 2025Paper
Computational modeling and optimization of CAR-T cell receptors targeting CD19 for enhanced efficacy and minimized toxicity
Preprint at Research Square
DOI 10.21203/rs.3.rs-6115435/v2(opens in a new tab) - 2025Paper
Recoding Genomic Elements with AI and Quantum Computation to Build the Next Generation Drug Discovery Platform
Preprints
Find on Google Scholar(opens in a new tab) - 2023Paper
Phase 3 efficacy and safety trial of proposed liraglutide biosimilar for reduction of glycosylated hemoglobin (HbA1c) in patients with Type 2 Diabetes
Diabetes Research and Clinical Practice
Find on Google Scholar(opens in a new tab) - 2023Paper
A comprehensive molecular and clinical investigation of approved anti-HCV drugs repurposing against SARS-CoV-2 infection
Vaccines, 11(3), 515
Find on Google Scholar(opens in a new tab) - 2022Paper
Assembly of nuclear dimers of PI3K regulatory subunits is regulated by the Cdc42-activated tyrosine kinase ACK
J Biol Chem
Find on Google Scholar(opens in a new tab) - 2021Paper
Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease
Journal of Biomolecular Structure and Dynamics, 39(9), 3099-3114. (2021)
Find on Google Scholar(opens in a new tab)
2010s13 entries
- 2019Paper
Assembly of novel, nuclear dimers of the PI3-Kinase regulatory subunits underpins the pro-proliferative activity of the Cdc42-activated tyrosine kinase, ACK
Biorxiv, 2019
Find on Google Scholar(opens in a new tab) - 2017Paper
A2B adenosine receptor antagonists: Design, synthesis and biological evaluation of novel xanthine derivatives
European Journal of Medicinal Chemistry, 151, 986-996. (2017)
Find on Google Scholar(opens in a new tab) - 2017Paper
Design and synthesis of novel, potent and selective hypoxanthine analogs as adenosine A1 receptor antagonists and their biological evaluation
Bioorganic & Medicinal Chemistry, 25(6), 1963-1975. (2017)
Find on Google Scholar(opens in a new tab) - 2017Paper
Discovery of liver-directed glucokinase activator having anti-hyperglycemic effect without hypoglycemia
European Journal of Medicinal Chemistry, 133, 268-286. (2017)
Find on Google Scholar(opens in a new tab) - 2016Paper
Discovery of a liver-directed glucokinase activator having anti-hyperglycemic effect without hypoglycemic potential
251st ACS National Meeting & Exposition, San Diego, CA, United States, March 13-17, 2016 (2016), MEDI-379
Find on Google Scholar(opens in a new tab) - 2015Granted patent
2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
Patent Number: 8940900. Filed: Feb 25, 2008. Date: Jan 27, 2015. Assignee: Advinus Therapeutics Private Limited
Search Google Patents(opens in a new tab) - 2012Paper
Discovery of pyrazole carboxylic acids as potent inhibitors of rat long chain L-2-hydroxy acid oxidase
Bioorganic & Medicinal Chemistry Letters (2012), 22(13), 4341-4347
Find on Google Scholar(opens in a new tab) - 2011Paper
Potent and Selective Inhibitors of Long Chain L-2-Hydroxy Acid Oxidase Reduced Blood Pressure in DOCA Salt-Treated Rats
ACS Medicinal Chemistry Letters (2011), 2(12), 919-923
Find on Google Scholar(opens in a new tab) - 2011Paper
Discovery of a potent and selective small molecule hGPR91 antagonist
Bioorganic & Medicinal Chemistry Letters (2011), 21(12), 3596-3602
Find on Google Scholar(opens in a new tab) - 2011Paper
RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes
European Journal of Pharmacology (2011), 655(1-3), 121
Find on Google Scholar(opens in a new tab) - 2011Granted patent
Substituted pyrrole derivatives and their use as HMG-CO inhibitors
Patent Number: 7923467. Filed: May 28, 2004. Date: April 12, 2011. Assignee: Ranbaxy Laboratories
Search Google Patents(opens in a new tab) - 2010Paper
AE9C90CB: a novel, bladder-selective muscarinic receptor antagonist for the treatment of overactive bladder
British Journal of Pharmacology (2010), 160(5), 1119-1127
Find on Google Scholar(opens in a new tab) - 2010Filed patent
Preparation of heterocyclic compounds as adrenergic receptor antagonists
IN 2005DE03142 A 20100305
Search Google Patents(opens in a new tab)
2000s61 entries
- 2009Paper
Ratiometric Ca+2 measurement in human recombinant muscarinic receptor subtypes using the Flexstation scanning fluorometer
Journal of Receptors and Signal Transduction (2009), 29(2), 100-106
Find on Google Scholar(opens in a new tab) - 2009Paper
RBx 6198: A novel α1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia
European Journal of Pharmacology (2009), 607(1-3), 213-219
Find on Google Scholar(opens in a new tab) - 2009Filed patent
Preparation of 3,6-disubstituted azabicyclo[3.1.0]hexane derivatives useful as therapeutic muscarinic receptor antagonists
IN 2005DN01810 A 20091009
Search Google Patents(opens in a new tab) - 2009Filed patent
A process for the synthesis of 1,4-disubstituted piperazine derivatives
IN 2005DE02911 A 20090731
Search Google Patents(opens in a new tab) - 2008Paper
Discovery of conformationally rigid 3-azabicyclo[3.1.0]hexane-derived dipeptidyl peptidase-IV inhibitors
Bioorganic & Medicinal Chemistry Letters (2008), 18(14), 4087-4091
Find on Google Scholar(opens in a new tab) - 2008Paper
Independent origin of 185delAG BRCA1 mutation in an Indian family
Neoplasma, 2008, 54(1):51-6
Find on Google Scholar(opens in a new tab) - 2008Granted patent
Azabicyclo derivatives as muscarinic receptor antagonists
Patent Number: 7446123. Filed: Jan 7, 2004. Date: Nov 4, 2008. Assignee: Ranbaxy Laboratories
Search Google Patents(opens in a new tab) - 2008Filed patent
Preparation of phenoxythiazolylalkylacetamide derivatives and analogs as glucokinase activators
WO 2008104994 A2 20080904
Search Google Patents(opens in a new tab) - 2007Paper
Comparative in vivo uroselectivity profiles of anticholinergics, tested in a novel anesthetized rabbit model
European Journal of Pharmacology (2007), 572(2-3), 207-212
Find on Google Scholar(opens in a new tab) - 2007Paper
Synthesis and optimization of novel and selective muscarinic M3 receptor antagonists
Bioorganic & Medicinal Chemistry Letters (2007), 17(18), 5256-5260
Find on Google Scholar(opens in a new tab) - 2007Paper
Role of peripheral 5-HT1A receptors in detrusor over activity associated with partial bladder outlet obstruction in female rats
European Journal of Pharmacology (2007), 561(1-3), 189-193
Find on Google Scholar(opens in a new tab) - 2007Filed patent
Preparation of azabicyclo[2.2.1]heptyl compounds as muscarinic receptor antagonists for treating respiratory, urinary, and gastrointestinal disorders
WO 2007110782 A1 20071004
Search Google Patents(opens in a new tab) - 2007Filed patent
Quinazoline derivatives as adrenergic receptor antagonists and their preparation, pharmaceutical compositions and use in the treatment of diseases
IN 2005DE01706 A 20070831
Search Google Patents(opens in a new tab) - 2007Filed patent
Thiazolidinedione derivatives as adrenergic receptor antagonists and their preparation, pharmaceutical compositions and use in the treatment of diseases
IN 2005DE01704 A 20070831
Search Google Patents(opens in a new tab) - 2007Filed patent
Piperazine derivatives as adrenergic receptor antagonists and their preparation, pharmaceutical compositions and use in the treatment of diseases
IN 2006DE00146 A 20070824
Search Google Patents(opens in a new tab) - 2007Filed patent
Preparation of imidazole derivatives as muscarinic receptor antagonists
WO 2007077510 A2 20070712
Search Google Patents(opens in a new tab) - 2007Filed patent
Preparation of 3-azabicyclo[3.2.1] octanes as muscarinic M3 receptor antagonists
WO 2007039884 A1 20070412
Search Google Patents(opens in a new tab) - 2007Filed patent
Derivatives of 3-azabicyclo[3.1.0]hexane as dipeptidyl peptidase-IV inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diseases
WO 2007029086 A2 20070315
Search Google Patents(opens in a new tab) - 2007Filed patent
Isoindoledione derivatives, processes for preparing them, pharmaceutical compositions containing them, and their uses as adrenergic receptor antagonists
WO 2007029156 A2 20070315
Search Google Patents(opens in a new tab) - 2007Filed patent
Preparation of succinimide and glutarimide piperidine and piperazine derivatives as α1a and/or α1d adrenergic receptor antagonists for treatment of benign prostatic hypertrophy
WO 2007029078 A2 20070315
Search Google Patents(opens in a new tab) - 2007Filed patent
Preparation of azabicyclic compounds as muscarinic receptor antagonists
WO 2007007282 A2 20070118
Search Google Patents(opens in a new tab) - 2007Filed patent
Preparation of isoquinoline derivatives as muscarinic receptor antagonists
WO 2007007281 A2 20070118
Search Google Patents(opens in a new tab) - 2006Paper
Molecular cloning, stable expression and cellular localization of human α1-adrenergic receptor subtypes: effect of charcoal/dextran treated serum on expression and localization of α1D-adrenergic receptor
Biotechnology Letters (2006), 28(21), 1731-1739. DOI:10.1007/s10529-006-9148-x
DOI 10.1007/s10529-006-9148-x(opens in a new tab) - 2006Paper
Statins and myotoxicity: a therapeutic limitation
Expert Opinion on Drug Safety (2006), 5(5), 651-666
Find on Google Scholar(opens in a new tab) - 2006Paper
Intermittent claudication: an overview
Atherosclerosis (Amsterdam, Netherlands) (2006), 187(2), 221-237
Find on Google Scholar(opens in a new tab) - 2006Paper
High level stable expression of pharmacologically active human M1-M5 muscarinic receptor subtypes in mammalian cells
Biotechnology Letters (2006), 28(2), 121-129
Find on Google Scholar(opens in a new tab) - 2006Filed patent
Preparation of benzotriazinones and phenoxazines as α1 adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia
WO 2006117760 A1 20061109
Search Google Patents(opens in a new tab) - 2006Filed patent
Preparation of 3,6-disubstituted azabicyclo[3.1.0]hexane derivatives as muscarinic receptor antagonists for use against respiratory, urinary and gastrointestinal diseases
WO 2006117754 A1 20061109
Search Google Patents(opens in a new tab) - 2006Filed patent
Metabolites of 2-{3-[4-(2-isopropoxyphenyl) piperazin-1-yl]-propyl}-3a,4,7,7a-tetrahydro-1H-isoindole-1,3(2H)-dione
WO 2006092710 A1 20060908
Search Google Patents(opens in a new tab) - 2006Filed patent
Azabicyclic compounds as muscarinic receptor antagonists and their preparation, pharmaceutical compositions and use for treatment of disease of the respiratory, urinary and gastrointestinal systems
WO 2006054162 A1 20060526
Search Google Patents(opens in a new tab) - 2006Filed patent
Isoindole derivatives as adrenergic receptor antagonists and their preparation, pharmaceutical compositions, and use for treatment of benign prostatic hyperplasia
WO 2006051374 A2 20060518
Search Google Patents(opens in a new tab) - 2006Filed patent
Alkynylpiperazine derivatives as α1-adrenergic receptor antagonists, their preparation, pharmaceutical compositions, and use in therapy
WO 2006051399 A1 20060518
Search Google Patents(opens in a new tab) - 2006Filed patent
3-Azabicyclo[3.1.0]hexane derivatives as muscarinic receptor antagonists and their preparation, pharmaceutical compositions, and use for treatment of prophylaxis of respiratory, urinary, or gastrointestinal diseases
WO 2006035282 A2 20060406
Search Google Patents(opens in a new tab) - 2006Filed patent
Azabicyclic compounds as muscarinic receptor antagonists and their preparation, pharmaceutical compositions, and use for treatment of prophylaxis of respiratory, urinary, or gastrointestinal diseases
WO 2006035303 A1 20060406
Search Google Patents(opens in a new tab) - 2006Filed patent
Preparation of 3,4-dihydroisoquinoline derivatives as muscarinic receptor antagonists for the treatment of respiratory, urinary and gastrointestinal diseases
WO 2006035280 A1 20060406
Search Google Patents(opens in a new tab) - 2006Filed patent
Preparation of phenyl-substituted amine diols and related compounds as muscarinic receptor antagonists for treating diseases such as those of the respiratory, urinary and gastrointestinal systems
WO 2006032994 A2 20060330
Search Google Patents(opens in a new tab) - 2006Filed patent
Preparation of piperazine derivatives as adrenergic receptor antagonists
WO 2006018815 A1 20060223
Search Google Patents(opens in a new tab) - 2006Filed patent
Preparation of pyrrolidine derivatives as muscarinic receptor antagonists
WO 2006018708 A2 20060223
Search Google Patents(opens in a new tab) - 2006Filed patent
Preparation of tetrahydronaphthyl azabicyclo[3.1.0] hexanes as muscarinic receptor antagonists
WO 2006016245 A1 20060216
Search Google Patents(opens in a new tab) - 2006Filed patent
Preparation of thiazolidinediones as adrenergic receptor antagonists
WO 2006013445 A2 20060209
Search Google Patents(opens in a new tab) - 2006Filed patent
Preparation of 9H-xanthene-9-carboxylic esters and related compounds as muscarinic receptor antagonists
WO 2006005980 A1 20060119
Search Google Patents(opens in a new tab) - 2005Paper
Benign prostatic hyperplasia: an insight into current investigational medical therapies
Expert Opinion on Investigational Drugs (2005), 14(11), 1359-1372
Find on Google Scholar(opens in a new tab) - 2005Paper
Design, synthesis and activity of novel derivatives of Oxybutynin and Tolterodine
Bioorganic & Medicinal Chemistry Letters (2005), 15(8), 2093-2096
Find on Google Scholar(opens in a new tab) - 2005Filed patent
1,4-Disubstituted piperazine derivatives useful as uro-selective α1-adrenoreceptor blockers
IN 2002DE00449 A 20050311
Search Google Patents(opens in a new tab) - 2005Filed patent
Preparation of piperazine derivatives, particularly piperazinyl-pyrrolidine-2,5-dione, piperazinyl-tetrahydroisoindole-1,3-dione, and piperazinyl-piperidine-2,6-dione derivatives, as adrenergic receptor antagonists for treating benign prostatic hyperplasia
WO 2005118537 A2 20051215
Search Google Patents(opens in a new tab) - 2005Filed patent
Preparation of condensed piperidine compounds acting as adrenergic receptor antagonists useful in the treatment of prostatic hyperplasia and lower urinary symptoms
WO 2005118591 A1 20051215
Search Google Patents(opens in a new tab) - 2005Filed patent
Preparation of piperazinyl cyclohexyl heterocycles as adrenergic receptor antagonists
WO 2005113498 A1 20051201
Search Google Patents(opens in a new tab) - 2005Filed patent
Combination therapy using adrenergic receptor antagonist in combination with muscarinic receptor antagonists and testosterone 5-reductase inhibitors for lower urinary tract symptoms
WO 2005092341 A1 20051006
Search Google Patents(opens in a new tab) - 2005Filed patent
Preparation of 1-alkylpiperazinyl-pyrrolidin-2,5-dione derivatives as adrenergic receptor antagonists for treating benign prostatic hyperplasia
WO 2005037282 A1 20050428
Search Google Patents(opens in a new tab) - 2005Filed patent
1-(Alkylpiperazinyl) pyrrolidine-2,5-dione derivatives, particularly 3,4-substituted -[3-[4-(2-alkoxyphenyl) piperazin-1-yl]propyl]pyrrolidine-2,5-diones, as adrenergic receptor antagonists, and their preparation, pharmaceutical compositions, and use in the treatment of benign prostatic hyperplasia and urinary symptoms
WO 2005037281 A1 20050428
Search Google Patents(opens in a new tab) - 2005Filed patent
Preparation of metabolites and prodrugs of 1-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propyl] piperidine-2,6-dione for use in the treatment of benign prostatic hyperplasia
WO 2005018643 A1 20050303
Search Google Patents(opens in a new tab) - 2004Paper
A study on hereditary breast cancer patients – Bioinformatic and Experimental approaches
Indo-Australian Conf. on Medical Biotechnology, proc. p.84
Find on Google Scholar(opens in a new tab) - 2004Filed patent
Preparation of substituted pyrrole derivatives as 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors
WO 2004106299 A2 20041209
Search Google Patents(opens in a new tab) - 2003Paper
Squalene epoxidase as hypocholesterolemic drug target revisited
Progress in Lipid Research (2003), 42(1), 37-50
Find on Google Scholar(opens in a new tab) - 2003Filed patent
Preparation of α,ω-dicarboximides as α1-adrenoceptor receptor antagonists for treatment of benign prostatic hyperplasia
WO 2003084928 A1 20031016
Search Google Patents(opens in a new tab) - 2003Filed patent
Preparation of N-(piperazinylpropyl)carboxamides as α1-adrenoceptor receptor antagonists for treatment of benign prostatic hyperplasia
WO 2003084541 A1 20031016
Search Google Patents(opens in a new tab) - 2003Book chapter
Digitalis and newer positive inotropic agents
In S.D. Seth, S.K. Manchanda, & S. Seth (Eds.), Recent advances in cardiovascular therapy of cardiovascular diseases. Jaypee Brothers Medical Publishers
Find on Google Scholar(opens in a new tab) - 2002Filed patent
Preparation of 2-[(4-arylpiperazino) alkyl]isindolediones as α1-adrenoceptor antagonists
WO 2002044151 A1 20020606
Search Google Patents(opens in a new tab) - 2001Paper
Differential regulation of striatal G protein levels following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration in C57 BL/6 mice
Neuroscience Letters (2001), 306(1-2), 21-24
Find on Google Scholar(opens in a new tab) - 2001Book chapter
Endothelin receptors: Targets for drug development
In: Gupta, S.K. Pharmacology and Therapeutics in the New Millennium, New Delhi, India, Dec 1999 (2001), 18-24
Find on Google Scholar(opens in a new tab) - 2000Paper
Endothelin-receptor antagonists: current and future perspectives
Drug Discovery Today (2000), 5(10), 455-464
Find on Google Scholar(opens in a new tab)
1990s5 entries
- 1998Paper
Protection against MPTP treatment by an analog of Pro-Leu-Gly-NH2 (PLG, MIF-1)
Peptides (New York) (1998), 19(2), 403-406
Find on Google Scholar(opens in a new tab) - 1998Paper
Development of neurogenic pulmonary edema at different grades of intracranial pressure in cats
Indian journal of physiology and pharmacology (1998), 42(1), 71-80
Find on Google Scholar(opens in a new tab) - 1997Paper
Modulation of dopamine receptor agonist-induced rotational behavior in 6-OHDA-lesioned rats by a peptidomimetic analog of Pro-Leu-Gly-NH2 (PLG)
Peptides (New York) (1997), 18(8), 1209-1215
Find on Google Scholar(opens in a new tab) - 1995Paper
Modulation of N-methyl-D-aspartate (NMDA) antagonist-induced darting behavior by the peptidomimetic PAMTA
Brain Research (1995), 682(1,2), 41-9
Find on Google Scholar(opens in a new tab) - 1991Paper
Modulation of morphine-induced antinociception by intracerebroventricularly administered captopril
Indian Journal of Experimental Biology (1991), 29(6), 543-5
Find on Google Scholar(opens in a new tab)
1980s6 entries
- 1989Paper
Cisplatin-induced emesis: effect of chemoreceptor trigger zone ablation in dogs
Asia Pacific Journal of Pharmacology (1989), 4(3), 209-11
Find on Google Scholar(opens in a new tab) - 1989Paper
Effect of intracerebroventricular administration of angiotensin II on emetic reflex in dogs
Indian Journal of Experimental Biology (1989), 27(6), 576-7
Find on Google Scholar(opens in a new tab) - 1989Paper
Role of endogenous opioids and histamine in morphine induced emesis
Indian Journal of Experimental Biology (1989), 27(1), 52-4
Find on Google Scholar(opens in a new tab) - 1989Paper
Opposing effect of apomorphine on antinociceptive activity of morphine: a dose-dependent phenomenon
Pain (1989), 36(2), 263-9
Find on Google Scholar(opens in a new tab) - 1988Paper
Characterization of dopamine receptor subtypes in chemoreceptor trigger zone involved in emesis in dogs
Asia Pacific Journal of Pharmacology (1988), 3(3), 135-9
Find on Google Scholar(opens in a new tab) - 1988Paper
Emetic profile of cisplatin in dogs
Asia Pacific Journal of Pharmacology (1988), 3(3), 131-3
Find on Google Scholar(opens in a new tab)
Undated1 entry
- —Filed patent
Preparation of (R)-(-)-5-[2-[[2-(2-ethoxyphenoxy)-ethyl]amino]propyl]-2-hydroxybenzenesulfonamide as an α1 adrenergic antagonist
Citation incomplete in our records — full details to be added.
Search Google Patents(opens in a new tab)
No entries match your search.
Try a different keyword, or clear the search to see everything.
Interested in a research collaboration?
We work with academia, labs and clinicians on cell and gene therapy research. Get in touch to discuss your project.
